I work with several biotech companies, I've observed project decentralization also become a large barrier to return on investment. Startups often develop a "go virtual" mindset prior to a lot of their products being ready for deployment. This coupled with the relative complexity of novel biotech products can burn through runway and make big investments riskier than an ad-revenue supported web product.